Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Puro Salt Makers gets ad-interim relief from Bombay HC

      Puro Salt Makers gets ad-interim relief from Bombay HC

      Ruby Khatun Khatun19 May 2018 3:33 PM IST
      AHMEDABAD: The Bombay High Court recently came to the rescue of Ruchir Modi’s wellness startup, Puro Wellness which is recognized under the Centre’s...
      Biocon sells 1.88 percent stake in Syngene for Rs 230 crore

      Biocon sells 1.88 percent stake in Syngene for Rs 230 crore

      Ruby Khatun Khatun19 May 2018 11:00 AM IST
      New Delhi: Biocon Ltd has sold close to 2% stake in its research arm Syngene International for an estimated Rs230 crore."Biocon, the promoter of...
      Alembic Pharma gets 1 observation from USFDA for Karkhadi unit

      Alembic Pharma gets 1 observation from USFDA for Karkhadi unit

      Ruby Khatun Khatun19 May 2018 10:40 AM IST
      New Delhi: Alembic Pharmaceuticals said the US health regulator has issued one observation on inspection of the company's Karkhadi facility in...
      Sun Pharma launches generic Welchol tablets in US

      Sun Pharma launches generic Welchol tablets in US

      Ruby Khatun Khatun19 May 2018 10:18 AM IST
      Mumbai: Sun Pharmaceutical Industries Ltd. announced that one of its wholly-owned subsidiaries has launched in US, the Authorized Generic (AG)...
      Granules India gets USFDA nod for haemorrhage drug

      Granules India gets USFDA nod for haemorrhage drug

      Ruby Khatun Khatun19 May 2018 10:00 AM IST
      New Delhi: The US Food and Drug Administration (USFDA) has approved Granules India's abbreviated new drug application (ANDA) for Methylergonovine 0.2...
      Vivimed Labs to acquire Hungary-based Soneas

      Vivimed Labs to acquire Hungary-based Soneas

      Ruby Khatun Khatun19 May 2018 9:45 AM IST
      New Delhi: Drug firm Vivimed Labs said it has inked pacts to acquire Hungary-based contract development and manufacturing firm Soneas for an...
      USFDA approves Amgen drug for prevention of migraines

      USFDA approves Amgen drug for prevention of migraines

      Ruby Khatun Khatun19 May 2018 9:30 AM IST
      Amgen Inc won U.S. Food and Drug Administration approval on Thursday for the first drug to prevent migraine headaches in adults.The drug, Aimovig,...
      IHH Healthcare extends acceptance period of enhanced revised offer for Fortis

      IHH Healthcare extends acceptance period of enhanced revised offer for Fortis

      Ruby Khatun Khatun18 May 2018 11:30 AM IST
      New Delhi: Malaysian firm IHH Healthcare Berhard said it has extended the acceptance period of its enhanced revised proposal for Fortis Healthcare to...
      Separate medical device cost and package rates under Ayushman Bharat: MTaI

      Separate medical device cost and package rates under Ayushman Bharat: MTaI

      Ruby Khatun Khatun18 May 2018 10:37 AM IST
      New Delhi: Medical Technology Association of India (MTaI), which represents leading research-based medical technology companies with significant...
      Cabinet approves MoU between India, Equatorial Guinea in medicine

      Cabinet approves MoU between India, Equatorial Guinea in medicine

      Ruby Khatun Khatun18 May 2018 10:15 AM IST
      New Delhi: The Union Cabinet chaired by Prime Minister Narendra Modi on Wednesday gave its ex-post facto approval to the Memorandum of Understanding...
      Pfizer gets FDA approval for first epoetin alfa biosimilar to treat anemia

      Pfizer gets FDA approval for first epoetin alfa biosimilar to treat anemia

      Ruby Khatun Khatun18 May 2018 10:00 AM IST
      The U.S. Food and Drug Administration (FDA) approved Retacrit (epoetin alfa-epbx) as a biosimilar to Epogen/Procrit (epoetin alfa) for the treatment...
      mfine raises Rs 28.5 crore from Prime Venture Partners, others

      mfine raises Rs 28.5 crore from Prime Venture Partners, others

      Ruby Khatun Khatun18 May 2018 10:00 AM IST
      New Delhi: Health-tech company mfine said it has raised USD 4.2 million (Rs 28.5 crore) funding led by Prime Venture Partners.Existing investors...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok